Diebold Nixdorf, Incorporated DBD
Set alert
56.05 USD +1.00 +1.82%
At close
56.21 +0.16 +0.29%
Pre-market · Nov 3, 8:31 AM ET
54.22 Day range 56.25
52.87 52-week range 92.09
- YTD
- -17.44%
- 1 year
- -5.24%
- Open
- 54.66
- Prev close
- 55.05
- Mkt cap
- 1.88B
- Vol
- 689.36K
- Avg vol
- 278.32K
- EPS
- 2.11
- P/E
- 26.56
- Div yield
- 0.00%
More statistics
- Low
- 54.22
- High
- 56.25
- Forward P/E
- 9.13
- Beta
- 1.24
- Short ratio
- 12.79
- Inst. own
- 137.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2027
- 50-d avg
- 65.15
- 200-d avg
- 74.96
- 1y target
- 85.00
3M chart
Events in this range
- Oct 15, 2026Rating: Wedbush · Outperform → Outperform
- Oct 27, 2026Rating: DA Davidson · Buy → Buy
- Oct 28, 2026Earnings: 1.34; estimate 1.31; surprise 2.29%
- Oct 29, 2026Rating: Wedbush · Outperform → Outperform
Signals (15)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 2026 | 4 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 28, 2026 | 6 days ago |
| RSI: Oversold | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 85.00 +51.7% upside
Now 56.05
- Target (low)
- 80.00
- Target (mean)
- 85.00
- Target (high)
- 90.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.60 | 1.58 – 1.62 | 2.75 | -41.9% | 1.07B | -3.2% | 3 |
| Next quarter | 1.00 | 0.82 – 1.18 | 0.67 | +49.3% | 905.90M | +1.6% | 2 |
| Current year | 4.68 | 4.65 – 4.70 | 4.73 | -1.1% | 3.88B | +1.9% | 3 |
| Next year | 6.14 | 5.65 – 7.01 | 4.68 | +31.2% | 3.98B | +2.5% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Oct 27, 2026 | DA Davidson | Maintained | Buy | Buy |
| Oct 15, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| May 4, 2026 | DA Davidson | Maintained | Buy | Buy |
| Apr 21, 2026 | DA Davidson | Maintained | Buy | Buy |
| Feb 13, 2026 | DA Davidson | Maintained | Buy | Buy |
| Feb 13, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 9, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 18, 2025 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 6, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Oct 28, 2025 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 19, 2025 | DA Davidson | Maintained | Buy | Buy |
| Aug 7, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Feb 27, 2025 | DA Davidson | Maintained | Buy | Buy |
| Aug 9, 2024 | DA Davidson | Maintained | Buy | Buy |
| Aug 8, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Jul 25, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| May 3, 2024 | Wedbush | Upgrade | Neutral | Outperform |
| Apr 25, 2024 | Wedbush | Reiterated | Neutral | Neutral |
| Feb 15, 2024 | Wedbush | Maintained | Neutral | Neutral |
| Feb 12, 2024 | Wedbush | Reiterated | Neutral | Neutral |
| Nov 10, 2023 | DA Davidson | Upgrade | Neutral | Buy |
| Nov 10, 2023 | Wedbush | Maintained | Neutral | Neutral |
| Oct 30, 2023 | Wedbush | Reiterated | Neutral | Neutral |
| Aug 18, 2023 | Wedbush | Maintained | Neutral | Neutral |